Skip to content

CapEx at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$376M+3.9%
Danaher logo
DanaherDHR
$237M-3.3%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$86.4M+10.6%
WAT
Waters CorporationWAT
$39M+50.0%
Agilent Technologies logo
Agilent TechnologiesA
$76M-33.3%
Illumina logo
IlluminaILMN
$38M+18.8%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's capex?
Revvity (RVTY) reported capex of $19.78M in Q1 2026.
How has Revvity's capex changed year-over-year?
Revvity's capex increased by 23.7% year-over-year, from $15.98M to $19.78M.
What is the long-term trend for Revvity's capex?
Over 4 years (2021 to 2025), Revvity's capex has grown at a -3.8% compound annual growth rate (CAGR), from $86.02M to $73.52M.
What does capex mean?
Cash spent on buying or upgrading physical assets like machinery and facilities.
How do you interpret capex?
Higher spending may indicate growth initiatives, while lower spending could suggest cost-cutting or asset maturity.
How does capex compare across companies?
Standard across all capital-intensive industries; peers in life sciences typically maintain consistent levels relative to revenue.